View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
April 20, 2021

Abbott begins supply of Covid-19 Ag self test in US 

Abbott has commenced the shipping of its BinaxNOW COVID-19 Ag Self Test to retailers across the US with availability to consumers expected soon. 

Abbott has commenced the shipping of its BinaxNOW COVID-19 Ag Self Test to retailers across the US with availability to consumers expected soon.

A lateral flow immunoassay, the test is intended for the qualitative identification of nucleocapsid protein antigen from SARS-CoV-2 with results obtained in just 15 minutes.

Authorised by the US Food and Drug Administration (FDA) for home use under an emergency use authorisation (EUA), the test can be performed using a self-collected direct anterior nasal swab specimen from people aged 15 years and above or adult-collected samples from children aged two years and above.

Individuals with or without symptoms or other epidemiological causes to suspect Covid-19 can conduct the test twice over three days with a gap of 36 hours between tests.

In the initial stage, the country’s most studied Covid-19 rapid test will be available at CVS Pharmacy, Walgreens and Walmart.

The test can be bought without needing a prescription and will be made available in food, drug and mass merchandisers soon.

Abbott president and CEO Robert Ford said: “Over the past year, Abbott has developed high-quality rapid testing and invested in US facilities to scale up manufacturing so we could bring affordable testing to Americans on a mass scale.

“We’re pleased to be working with the country’s leading retailers to provide broad access to this affordable test so that it gets out into the communities that need it most.”

Abbott intends to produce tens of millions of BinaxNOW Self Tests on a monthly basis and will expand capacity depending on demand.

To be sold in two-count packs for a manufacturer’s suggested retail price (MSRP) of $23.99, the BinaxNOW Self Test is the most reasonably priced over-the-counter Covid-19 rapid test available in the US.

The latest test utilises the same technology as the currently approved BinaxNOW test, which has been available since last August for serial symptomatic and asymptomatic testing.

Related Companies

Free Report

Navigate your business through the ‘new normal’

COVID-19 continues to dominate headlines the world over. It has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities.  Faced with an explosion of conflicting information on how to plan and implement successful recovery strategies, decision-makers are in dire need of a single, reliable source of intelligence.   GlobalData’s COVID-19 Executive Briefing gives you access to unparalleled data and insights to successfully navigate the uncertain road to recovery across the world’s largest industries. Understand every aspect of this disruptive theme by delving into: 
  •  COVID-19 infection update, with statistics on the spread, testing by country, as well as the latest data on vaccines and therapeutic developments 
  • Economic impact overview, covering stock market indices, GDP, unemployment rates, policy responses & GlobalData’s economic recovery scorecards 
  • Sector developments, with access to sector insight summaries, cross-sector indices and the leaders and laggards in each industry vertical 
Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today. 
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy